-+ 0.00%
-+ 0.00%
-+ 0.00%

Lakewood-Amedex Biotherapeutics flags new press release available on Nu-3 resistance data

PUBT·07/22/2026 12:04:25
Listen to the news
Lakewood-Amedex Biotherapeutics flags new press release available on Nu-3 resistance data
  • Lakewood-Amedex published a July 22, 2026 release highlighting new resistance data for Nu-3, its Phase 2-ready infected diabetic foot ulcer candidate.
  • Nu-3 showed no induced resistance in a serial-passage study, supporting its membrane-disruption mechanism and positioning in antimicrobial-resistance-focused development.
  • Release: https://lakewoodamedex.com/


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lakewood-Amedex Biotherapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY09340) on July 22, 2026, and is solely responsible for the information contained therein.